Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-19 4:05 pm Sale |
2024-11-15 | 13G | TFF Pharmaceuticals, Inc. TFFP |
CARLSON CAPITAL L P | 124,000 3.450% |
-93,960 (-43.11%) |
Filing History |
| 2024-11-14 3:37 pm Purchase |
2024-09-30 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Armistice Capital, LLC | 359,382 9.990% |
359,382 (New Position) |
Filing History |
| 2024-05-08 5:13 pm Purchase |
2024-04-29 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Mitchell P. Kopin | 155,589 4.990% |
155,589 (New Position) |
Filing History |
| 2024-05-08 4:26 pm Purchase |
2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
CARLSON CAPITAL L P | 217,960 9.120% |
144,280 (+195.82%) |
Filing History |
| 2024-02-14 6:48 pm Sale |
2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
LYTTON LAURENCE W | 11,900 0.100% |
-113,129 (-90.48%) |
Filing History |
| 2023-02-14 3:32 pm Sale |
2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Lung Therapeutics Inc. | 30,920 2.100% |
-58,480 (-65.41%) |
Filing History |
| 2023-02-13 4:03 pm Sale |
2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
LYTTON LAURENCE W | 125,029 8.400% |
-477 (-0.38%) |
Filing History |
| 2023-02-09 4:30 pm Sale |
2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
CARLSON CAPITAL L P | 73,680 5.100% |
-14,080 (-16.04%) |
Filing History |
| 2022-11-28 4:17 pm Purchase |
2022-11-22 | 13G | TFF Pharmaceuticals, Inc. TFFP |
CARLSON CAPITAL L P | 87,760 6.200% |
87,760 (New Position) |
Filing History |
| 2022-11-23 1:01 pm Purchase |
2022-11-18 | 13G | TFF Pharmaceuticals, Inc. TFFP |
LYTTON LAURENCE W | 125,506 8.800% |
125,506 (New Position) |
Filing History |
| 2022-02-14 4:10 pm Sale |
2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Corriente Advisors LLC | 0 0.000% |
-54,000 (Position Closed) |
Filing History |
| 2022-02-14 3:07 pm Sale |
2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Lung Therapeutics Inc. | 89,400 8.810% |
-28,600 (-24.24%) |
Filing History |
| 2022-02-14 08:24 am Sale |
2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Nantahala Capital Management, LLC | 0 0.000% |
-70,539 (Position Closed) |
Filing History |
| 2021-02-16 06:33 am Purchase |
2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Corriente Advisors LLC | 54,000 6.070% |
54,000 (New Position) |
Filing History |
| 2021-02-16 06:25 am Purchase |
2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Nantahala Capital Management, LLC | 70,539 7.900% |
70,539 (New Position) |
Filing History |
| 2021-02-03 3:10 pm Sale |
2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Lung Therapeutics Inc. | 118,000 13.300% |
-42,000 (-26.25%) |
Filing History |